Evernorth’s Accredo Earns URAC Rare Disease Pharmacy Center of Excellence Designation

February 10, 22

Clinically Speaking: February 2022 COVID-19 Update

Testing for COVID-19 has proven to be an important tool to help mitigate the spread of Omicron and other variants.

Cynthia Zelis, MD, MBA, February 11, 22

With Heavy Alcohol Use Increasing, Evernorth Expands Access To Treatment with Monument’s Virtual Services

Through the Evernorth Behavioral Health Network, customers can now use Monument’s online peer support, personalized therapy, and provider-prescribed medication to help them achieve sobriety or moderat...

February 15, 22

Chris Lehmuth

Marie Vidaic, PharmD

The Lab by Evernorth: Contact Us_2640

Hybrid Health Care

Interest + Investment Disconnect

Access and Affordability

Evernorth Research Institute